GS Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-200
| Closed | -$5.07K | – | 120 |
|
|
2025
Q1 | $5.07K | Hold |
200
| – | – | ﹤0.01% | 108 |
|
|
2024
Q4 | $5.31K | Hold |
200
| – | – | ﹤0.01% | 110 |
|
|
2024
Q3 | $5.79K | Hold |
200
| – | – | ﹤0.01% | 110 |
|
|
2024
Q2 | $5.6K | Hold |
200
| – | – | ﹤0.01% | 109 |
|
|
2024
Q1 | $5.55K | Hold |
200
| – | – | ﹤0.01% | 115 |
|
|
2023
Q4 | $5.76K | Hold |
200
| – | – | ﹤0.01% | 112 |
|
|
2023
Q3 | $6.63K | Hold |
200
| – | – | ﹤0.01% | 107 |
|
|
2023
Q2 | $7.34K | Hold |
200
| – | – | ﹤0.01% | 110 |
|
|
2023
Q1 | $8.16K | Hold |
200
| – | – | ﹤0.01% | 115 |
|
|
2022
Q4 | $10.2K | Hold |
200
| – | – | 0.01% | 110 |
|
|
2022
Q3 | $9K | Hold |
200
| – | – | 0.01% | 109 |
|
|
2022
Q2 | $10K | Hold |
200
| – | – | 0.01% | 115 |
|
|
2022
Q1 | $10K | Hold |
200
| – | – | 0.01% | 114 |
|
|
2021
Q4 | $12K | Hold |
200
| – | – | 0.01% | 112 |
|
|
2021
Q3 | $9K | Buy |
+200
| New | +$8.86K | ﹤0.01% | 120 |
|
|
2021
Q1 | – | Sell |
-200
| Closed | -$7K | – | 103 |
|
|
2020
Q4 | $7K | Buy |
+200
| New | +$7.34K | 0.01% | 108 |
|
|
2020
Q3 | – | Sell |
-211
| Closed | -$6.54K | – | 91 |
|
|
2020
Q2 | $6.54K | Hold |
211
| – | – | 0.01% | 95 |
|
|
2020
Q1 | $6.53K | Sell |
211
-105
| -33% | -$3.58K | 0.01% | 95 |
|
|
2019
Q4 | $10.9K | Buy |
316
+105
| +50% | +$3.74K | 0.01% | 97 |
|
|
2019
Q3 | $7.19K | Hold |
211
| – | – | 0.01% | 101 |
|
|
2019
Q2 | $8.66K | Hold |
211
| – | – | 0.01% | 94 |
|
|
2019
Q1 | $8.49K | Hold |
211
| – | – | 0.01% | 95 |
|
|
2018
Q4 | $8.73K | Hold |
211
| – | – | 0.01% | 97 |
|
|
2018
Q3 | $8.81K | Sell |
211
-105
| -33% | -$4.04K | 0.01% | 101 |
|
|
2018
Q2 | $10.9K | Hold |
316
| – | – | 0.01% | 100 |
|
|
2018
Q1 | $10.6K | Hold |
316
| – | – | 0.01% | 92 |
|
|
2017
Q4 | $10.9K | Hold |
316
| – | – | 0.01% | 94 |
|
|
2017
Q3 | $10.7K | Sell |
316
-546
| -63% | -$17.5K | 0.01% | 97 |
|
|
2017
Q2 | $27.5K | Buy |
+862
| New | +$27.2K | 0.02% | 92 |
|
Other funds holding PFE
GS Investments's PFE Position: Q2 2025 in Review
GS Investments sold out of Pfizer (PFE) in Q2 2025, closing a stake of 200 shares — an estimated $5.07K sold.
GS Investments first reported a position in PFE in Q2 2017 and held it in 29 quarters. The position peaked at $27.5K in Q2 2017. 2,813 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- GS Investments reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- GS Investments sold 200 Pfizer shares in Q2 2025, an estimated $5.07K.
- GS Investments first reported a position in Pfizer in Q2 2017 and held it in 29 quarters.
- GS Investments's Pfizer position peaked at $27.5K in Q2 2017.
- 2,813 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on GS Investments's 13F filing for Q2 2025, filed 7 Aug 2025.